Related Experiment Video
Updated: Aug 14, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
Iron supplements reduce erythrocyte copper-zinc superoxide dismutase activity in term, breastfed infants
Magnus Domellöf1, Kathryn G Dewey, Roberta J Cohen
1Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden. magnus.domellof@pediatri.umu.se
Insights
Iron supplements may negatively affect copper status in infants. Studies show iron supplementation reduced copper/zinc-dependent superoxide dismutase activity, indicating potential health implications.
Area of Science:
- Pediatric Nutrition
- Mineral Metabolism
- Infant Health
Background:
- Copper is essential for infant development.
- Iron supplementation is common for infants.
- Potential interactions between iron and copper require investigation.
Purpose of the Study:
- To determine if iron supplements impact copper status in infants.
- To assess the effect of iron supplementation timing on copper levels.
Main Methods:
- Randomized controlled trial with 214 infants.
- Iron or placebo supplementation from 4-9 months.
- Plasma copper and CuZn-SOD activity measured at 4, 6, and 9 months.
Main Results:
- Plasma copper increased with age.
- Honduran infants had higher copper status than Swedish infants.
- Iron supplementation from 4-9 months reduced CuZn-SOD activity.
Conclusions:
- Iron supplementation may negatively affect copper status.
- Differences in copper status observed between infant groups.
- Further research is needed to understand clinical implications.
Aim:
To investigate whether iron supplements compromise copper status in infants.
Methods:
214 healthy, term, breastfed Swedish and Honduran infants were randomized to (1) iron supplements (1 mg/kg/d) from 4-9 mo of age, (2) iron supplements from 6-9 mo, or (3) placebo. Blood samples were obtained at 4, 6, and 9 mo and analyzed for plasma copper (p-Cu) and, at 9 mo, for copper/zinc-dependent superoxide dismutase (CuZn-SOD) activity.
Results:
P-Cu increased with infant age. At 9 mo, Honduran infants had significantly higher p-Cu (1.40+/-0.29 vs 1.09+/-0.22 mg/l, p<0.001) and CuZn-SOD activity (1.09+/-0.29 vs 0.93+/-0.21 U/mg Hb, p<0.001) than Swedish infants. Infants receiving iron supplements from 4-9 mo had significantly lower CuZn-SOD at 9 mo of age (0.95+/-0.27 vs 1.08+/-0.24 U/mg Hb, p=0.023) than those receiving placebo.
Conclusion:
There is a physiologic increase in p-Cu during the first 9 mo of life. Differences in copper status between Swedish and Honduran infants may be due to genetic or nutritional differences. Iron supplementation decreases CuZn-SOD activity, probably due to a negative effect on copper status. Possible clinical implications remain to be elucidated.
More Related Videos
Related Concept Videos
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Lifecycle of Erythrocytes
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Erythropoiesis
Microbes and Other Elemental Cycles

